STRATEGIES FOR PREVENTION OF ANTHRACYCLINE CARDIOTOXICITY

被引：57

作者：

BASSER, RL

GREEN, MD

机构：

[1] LUDWIG INST CANC RES,PARKVILLE,VIC 3050,AUSTRALIA

[2] ROYAL MELBOURNE HOSP,PARKVILLE,VIC 3050,AUSTRALIA

来源：

CANCER TREATMENT REVIEWS | 1993年 / 19卷 / 01期

关键词：

D O I：

10.1016/0305-7372(93)90027-O

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：57 / 77

页数：21

共 151 条

[1] INTENSELY POTENT MORPHOLINYL ANTHRACYCLINES [J].

ACTON, EM ;

TONG, GL ;

MOSHER, CW ;

WOLGEMUTH, RL .

JOURNAL OF MEDICINAL CHEMISTRY, 1984, 27 (05) :638-645

[2]

ADACHI T, 1983, J PHARMACOBIO-DYNAM, V6, P114

[3]

ALDERTON P, 1990, CANCER RES, V50, P5136

[4]

ALDERTON PM, 1992, CANCER RES, V52, P194

[5] SERIAL ASSESSMENT OF DOXORUBICIN CARDIOTOXICITY WITH QUANTITATIVE RADIONUCLIDE ANGIOCARDIOGRAPHY [J].

ALEXANDER, J ;

DAINIAK, N ;

BERGER, HJ ;

GOLDMAN, L ;

JOHNSTONE, D ;

REDUTO, L ;

DUFFY, T ;

SCHWARTZ, P ;

GOTTSCHALK, A ;

ZARET, BL .

NEW ENGLAND JOURNAL OF MEDICINE, 1979, 300 (06) :278-283

[6]

BACHUR NR, 1977, MOL PHARMACOL, V13, P901

[7]

BACHUR NR, 1978, CANCER RES, V38, P1745

[8]

BASSER R, 1992, P AM SOC CLIN ONCOL, V11, P123

[9] CYTO-TOXIC ALDEHYDES ORIGINATING FROM THE PEROXIDATION OF LIVER MICROSOMAL LIPIDS - IDENTIFICATION OF 4,5-DIHYDROXYDECENAL [J].

BENEDETTI, A ;

COMPORTI, M ;

FULCERI, R ;

ESTERBAUER, H .

BIOCHIMICA ET BIOPHYSICA ACTA, 1984, 792 (02) :172-181

[10] IRON(III) ADRIAMYCIN AND IRON(III) DAUNORUBICIN COMPLEXES - PHYSICOCHEMICAL CHARACTERISTICS, INTERACTION WITH DNA, AND ANTITUMOR-ACTIVITY [J].

BERALDO, H ;

GARNIERSUILLEROT, A ;

TOSI, L ;

LAVELLE, F .

BIOCHEMISTRY, 1985, 24 (02) :284-289

← 1 2 3 4 5 6 7 8 9 10 →